Previous close | 0.0000 |
Open | 0.0000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0000 - 0.0001 |
52-week range | 0.0000 - 0.0001 |
Volume | |
Avg. volume | 28,541,006 |
Market cap | 2.908M |
Beta (5Y monthly) | 19.76 |
PE ratio (TTM) | ∞ |
EPS (TTM) | 0.0000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DENVER, CO, March 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to offer this open letter to shareholders and investors from the CEO of its new subsidiary Innovative Outcomes, Inc. (Innovative Outcomes) a prominent player in the multi-billion-dollar medical wound care industry. CEO of Innovative Outcomes, Inc. Kevin Lamb: For the last 25 years my passion has focused on the medical industry;
DENVER, CO, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce its acquisition of Innovative Outcomes, Inc. (Innovative Outcomes), a prominent player in the multi-billion-dollar medical wound care industry currently posting five million dollars per year in revenue. The strategic move is set to further strengthen Innovative Outcomes presence in the healthcare sector and enhance i
DENVER, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) continues its strategic initiative to complete the acquisition of Innovative Outcomes, Inc. Innovative Outcomes is a leader in the medical wound care health segment and is poised for explosive growth in 2024 and beyond. It is estimated chronic wounds impact more than 2.5% of the population of the United States. The problem: many patients are immobile and/or unable to be seen by clinical provide